forms of glp-1 Agonists: A Comprehensive Overview The GLP-1 Agonists and Obesity:

[DOI] [PubMed] [Google Scholar] 87.Ehses JA, Pelech SL, Pederson RA, McIntosh CH (2002) Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway

While bariatric procedures such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy produce substantial initial weight loss, physiological adaptations and behavioral factors can contribute to gradual weight recurrence

These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)

Do not administer TOUJEO intravenously, intramuscularly, or in an insulin pump